A patient experiencing intolerable side effects on fluoxetine 20 mg orally daily needs to be switched to an equivalent dose of sertraline; what dose is most appropriate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Sertraline Dose When Switching from Fluoxetine 20 mg

Switch to sertraline 50 mg by mouth daily when converting from fluoxetine 20 mg daily. 1

Evidence-Based Dose Equivalence

The most rigorous dose-equivalence study, which analyzed 83 randomized controlled trials with over 14,000 participants, established that fluoxetine 40 mg daily is equivalent to sertraline 98.5 mg daily 1. Using this conversion ratio:

  • Fluoxetine 20 mg (half of 40 mg) converts to approximately sertraline 50 mg daily 1
  • This represents a 1:2.5 conversion ratio (20 mg fluoxetine → 50 mg sertraline) 1

Clinical Validation of the Conversion

Multiple clinical studies support this dosing strategy:

  • A Veterans Affairs study demonstrated that converting fluoxetine to sertraline at a ratio of 50 mg sertraline per 20 mg fluoxetine maintained depression control without loss of efficacy 2
  • The American College of Physicians recommends direct switching between SSRIs without washout periods, starting sertraline at 50 mg when transitioning from other SSRIs 3
  • Sertraline 50 mg represents the standard initial therapeutic dose with established efficacy in major depressive disorder 4, 5

Practical Switching Algorithm

Day 1 of switch:

  • Stop fluoxetine 20 mg 3
  • Start sertraline 50 mg the next day without washout period 3
  • No overlap or tapering required when switching between these SSRIs 3

Weeks 2-4:

  • Monitor for therapeutic response and tolerability 3
  • If inadequate response after 2-4 weeks, titrate to 100 mg daily 3
  • Maximum dose 200 mg daily if needed, though most patients respond to 50-100 mg 4, 5

Important Caveats

Fluoxetine's long half-life: Fluoxetine and its active metabolite norfluoxetine have half-lives of 1-3 days and 7-15 days respectively, meaning fluoxetine will continue exerting serotonergic effects for weeks after discontinuation 6. This built-in "washout" reduces discontinuation syndrome risk but means full sertraline effects may not be apparent immediately 6.

Why NOT 25 mg: This dose is subtherapeutic for depression and would delay therapeutic response 3. The 25 mg dose is only appropriate for initial tolerability testing in highly sensitive patients, not for standard SSRI switching 3.

Why NOT 100 mg initially: Starting at 100 mg provides no additional benefit over 50 mg in most patients and increases the risk of side effects including sexual dysfunction 7, 5. Dose escalation should only occur after assessing response at 50 mg 7.

Why NOT 200 mg: This represents a 10-fold equivalent dose (fluoxetine 80 mg equivalent) and would constitute overdosing, significantly increasing adverse effects without proportional efficacy gains 1, 5.

Monitoring Requirements

  • Assess for discontinuation symptoms (dizziness, fatigue, headaches, nausea) in the first 1-2 weeks, though these are less common with fluoxetine due to its long half-life 6, 3
  • Monitor for therapeutic response at 2-4 weeks 3
  • Screen for sexual dysfunction, as sertraline causes this in approximately 14% of males and 6% of females 8
  • Watch for serotonin syndrome symptoms during the transition period, though risk is low with appropriate switching 3

References

Research

Clinical effect of converting antidepressant therapy from fluoxetine to sertraline.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1995

Guideline

Switching from Citalopram to Sertraline

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Sertraline Dosage and Efficacy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

SSRI-Associated Sexual Dysfunction

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.